SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0000891293-17-000003
Filing Date
2017-01-03
Accepted
2017-01-03 17:35:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12G/A omm_us-75342248xv2xctixxx2.htm 8-A12G/A 43186
  Complete submission text file 0000891293-17-000003.txt   44264
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-A12G/A | Act: 34 | File No.: 000-28386 | Film No.: 17502928
SIC: 2834 Pharmaceutical Preparations